Hints and tips:
Related Special Reports
...’s Astellas Pharma on espionage charges....
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
...Japan has said 17 of its citizens have been detained since China passed a counter-espionage law in 2014, of whom five remain in detention, including an executive of Astellas Pharma who was taken into custody...
...The arrest also comes amid increasing tensions between China and Japan over economic security, particularly around advanced technology such as semiconductors....
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...Scientists at the new site will be focused on the intersection of neuroscience, inflammation and immunology, hoping to use the latest technologies such as 3D printing of cells to better understand the brain...
...Pharma group and hit London-headquartered Deloitte with a record fine....
...Pharma; levied a record fine against Deloitte, and amended its espionage law to cover ordinary business activities....
...India’s biggest IPO so far this year has been a Rs43.2bn ($525mn) flotation by Mankind Pharma....
...It has also raided US due diligence firm Mintz and Bain, the consultancy, and detained an executive from Japan’s Astellas Pharma group....
...Pharma group....
...Both the tech and pharma industries are now structured in this way: small and innovative start-ups build new products in the hope of being bought by large platforms....
...Pfizer’s expertise in mRNA — the core technology used in the Covid vaccine — also provides opportunities, he added. But in the short term, Pfizer is reliant on its existing pipeline....
...New Jersey-based J&J said the Abiomed deal would broaden its medical technology division and hone its focus on cardiovascular disease....
...“Illumina’s mission is to save lives through groundbreaking technology and innovation, and our advocacy work reflects all aspects of that mission.”...
...In March, the state also detained without explanation five local employees of US due diligence firm Mintz Group and arrested a Japanese worker at pharmacy company Astellas Pharma on allegations of espionage...
...The defining technology merger of 1998 was Microsoft’s purchase of Compu-Global-Hyper-Mega-Net, Homer Simpson’s internet start-up, for an undisclosed price....
...She adds: “If the head of a big pharma company were a rogue player, you would know that investing in that company might bring you very high returns but also that it’s going to be volatile and you may have...
...“These are pharma companies, these are the food companies, technology firms,” she said....
...The initial portfolio is heavy with drug and biotech companies, such as Japan’s Astellas Pharma, Germany’s Fresenius Medical Care and Biogen of the US....
...They added that companies should negotiate areas such as delivery swaps with countries that already have high coverage, and commit to greater expertise and technology transfer including licensing rights....
International Edition